290 related articles for article (PubMed ID: 24781315)
1. Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11).
Sibiude J; Mandelbrot L; Blanche S; Le Chenadec J; Boullag-Bonnet N; Faye A; Dollfus C; Tubiana R; Bonnet D; Lelong N; Khoshnood B; Warszawski J
PLoS Med; 2014 Apr; 11(4):e1001635. PubMed ID: 24781315
[TBL] [Abstract][Full Text] [Related]
2. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
[TBL] [Abstract][Full Text] [Related]
3. Safety of pediatric HIV elimination: the growing population of HIV- and antiretroviral-exposed but uninfected infants.
Mofenson LM; Watts DH
PLoS Med; 2014 Apr; 11(4):e1001636. PubMed ID: 24781352
[TBL] [Abstract][Full Text] [Related]
4. Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication.
Watts DH; Huang S; Culnane M; Kaiser KA; Scheuerle A; Mofenson L; Stanley K; Newell ML; Mandelbrot L; Delfraissy JF; Cunningham CK
J Perinat Med; 2011 Mar; 39(2):163-70. PubMed ID: 21142844
[TBL] [Abstract][Full Text] [Related]
5. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Gibb DM; Kizito H; Russell EC; Chidziva E; Zalwango E; Nalumenya R; Spyer M; Tumukunde D; Nathoo K; Munderi P; Kyomugisha H; Hakim J; Grosskurth H; Gilks CF; Walker AS; Musoke P;
PLoS Med; 2012; 9(5):e1001217. PubMed ID: 22615543
[TBL] [Abstract][Full Text] [Related]
7. Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.
Brogly SB; Abzug MJ; Watts DH; Cunningham CK; Williams PL; Oleske J; Conway D; Sperling RS; Spiegel H; Van Dyke RB
Pediatr Infect Dis J; 2010 Aug; 29(8):721-7. PubMed ID: 20539252
[TBL] [Abstract][Full Text] [Related]
8. Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs.
Veroniki AA; Antony J; Straus SE; Ashoor HM; Finkelstein Y; Khan PA; Ghassemi M; Blondal E; Ivory JD; Hutton B; Gough K; Hemmelgarn BR; Lillie E; Vafaei A; Tricco AC
PLoS One; 2018; 13(6):e0198447. PubMed ID: 29912896
[TBL] [Abstract][Full Text] [Related]
9. The Antiretroviral Pregnancy Registry: Three decades of prospective monitoring for birth defects.
Albano JD; Scheuerle AE; Watts DH; Beckerman KP; Mofenson LM; Pikis A; Vannappagari V; Seekins D; Cook TS; Tilson H;
Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5801. PubMed ID: 38798093
[TBL] [Abstract][Full Text] [Related]
10. Prenatal exposure to zidovudine and risk for ventricular septal defects and congenital heart defects: data from the Antiretroviral Pregnancy Registry.
Vannappagari V; Albano JD; Koram N; Tilson H; Scheuerle AE; Napier MD
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():6-10. PubMed ID: 26687320
[TBL] [Abstract][Full Text] [Related]
11. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
[TBL] [Abstract][Full Text] [Related]
12. Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry.
Vannappagari V; Koram N; Albano J; Tilson H; Gee C
BJOG; 2016 May; 123(6):910-6. PubMed ID: 26269220
[TBL] [Abstract][Full Text] [Related]
13. Birth Defects After Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy: A Multicohort Analysis.
Martinez de Tejada B; Gayet-Ageron A; Winterfeld U; Thorne C; Favarato G;
J Acquir Immune Defic Syndr; 2019 Mar; 80(3):316-324. PubMed ID: 30570524
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
15. Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
Venkatesh KK; Farhad M; Fenton T; Moodley D; Naik S; Nakabiito C; Fairlie L; Fowler MG; Stringer JSA; Chi BH
AIDS; 2019 Dec; 33(15):2403-2413. PubMed ID: 31764105
[TBL] [Abstract][Full Text] [Related]
16. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
Thorne C; Newell ML
Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
[TBL] [Abstract][Full Text] [Related]
17. Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009.
Prieto LM; González-Tomé MI; Muñoz E; Fernández-Ibieta M; Soto B; Álvarez A; Navarro ML; Roa MÁ; Beceiro J; de José MI; Olabarrieta I; Lora D; Ramos JT;
BMC Infect Dis; 2014 Dec; 14():700. PubMed ID: 25808698
[TBL] [Abstract][Full Text] [Related]
18. Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa.
Manicklal S; van Niekerk AM; Kroon SM; Hutto C; Novak Z; Pati SK; Chowdhury N; Hsiao NY; Boppana SB
Clin Infect Dis; 2014 May; 58(10):1467-72. PubMed ID: 24567248
[TBL] [Abstract][Full Text] [Related]
19. Birth defects following exposure to efavirenz-based antiretroviral therapy during pregnancy: a study at a regional South African hospital.
Bera E; McCausland K; Nonkwelo R; Mgudlwa B; Chacko S; Majeke B
AIDS; 2010 Jan; 24(2):283-9. PubMed ID: 19864931
[TBL] [Abstract][Full Text] [Related]
20. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.
Amani-Bosse C; Dahourou DL; Malateste K; Amorissani-Folquet M; Coulibaly M; Dattez S; Emieme A; Barry M; Rouzioux C; N'gbeche S; Yonaba C; Timité-Konan M; Mea V; Ouédraogo S; Blanche S; Meda N; Seguin-Devaux C; Leroy V
J Int AIDS Soc; 2017 Apr; 20(1):21362. PubMed ID: 28453240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
